Compassionate Use of Vonsetamig
- Status
- AVAILABLE
- Phase
- N/A
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
Study of 3 Monoclonal Antibodies (REGN9933, REGN7508, and REGN9533) in Adult Participants With End-Stage Kidney Disease on Hemodialysis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Safety and Tolerability of REGN17235 in Adult Participants With Clonal Cytopenia of Undetermined Significance and Low-Risk Myelodysplastic Syndrome With SF3B1 Mutation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Identify and Characterize Adults and Pediatric Participants With Cat and/or Birch Allergy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Phase 1b/2 Study of IV Sarilumab in Adult With RA
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Status
- RECRUITING
- Phase
- PHASE2
REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat Allergy
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
- Status
- RECRUITING
- Phase
- PHASE4
Follow-up of a French National Cohort of Patients With Cutaneous Squamous Cell Carcinoma Requiring Systemic Treatment.
- Status
- RECRUITING
- Phase
- N/A